Report cover image

Global Oxycodone Hydrochloride Analgesic Market Analysis and Forecast 2025-2031

Publisher APO Research, Inc.
Published Jul 08, 2025
Length 193 Pages
SKU # APRC20283809

Description

Summary

According to APO Research, The global Oxycodone Hydrochloride Analgesic market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Oxycodone Hydrochloride Analgesic is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Oxycodone Hydrochloride Analgesic is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Oxycodone Hydrochloride Analgesic is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Oxycodone Hydrochloride Analgesic is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Oxycodone Hydrochloride Analgesic include Teva Pharmaceutical Industries Ltd, Mylan, Wellso Pharmaceutical, Purdue Pharma, NEPHARM, Napp Pharmaceuticals, Mallinckrodt, Epic Pharma, LLC and Amneal Pharmaceuticals, Inc.(Impax), etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Oxycodone Hydrochloride Analgesic, market size. Analyses of the global market trends, with historic market revenue data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Oxycodone Hydrochloride Analgesic, also provides the revenue of main regions and countries. Of the upcoming market potential for Oxycodone Hydrochloride Analgesic, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Oxycodone Hydrochloride Analgesic revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Oxycodone Hydrochloride Analgesic market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2020 to 2031. Evaluation and forecast the market size for Oxycodone Hydrochloride Analgesic revenue, projected growth trends, production technology, application and end-user industry.

Oxycodone Hydrochloride Analgesic Segment by Company

Teva Pharmaceutical Industries Ltd
Mylan
Wellso Pharmaceutical
Purdue Pharma
NEPHARM
Napp Pharmaceuticals
Mallinckrodt
Epic Pharma, LLC
Amneal Pharmaceuticals, Inc.(Impax)
Oxycodone Hydrochloride Analgesic Segment by Type

Tablets
Injections
Oxycodone Hydrochloride Analgesic Segment by Application

Hospital
Clinic
Others
Oxycodone Hydrochloride Analgesic Segment by Region

North America
United States
Canada
Mexico
Europe

Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific

China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America

Brazil
Argentina
Chile
Middle East & Africa

Egypt
South Africa
Israel
Türkiye
GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oxycodone Hydrochloride Analgesic market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Oxycodone Hydrochloride Analgesic and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oxycodone Hydrochloride Analgesic.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Oxycodone Hydrochloride Analgesic in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Oxycodone Hydrochloride Analgesic company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Oxycodone Hydrochloride Analgesic revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

193 Pages
1 Market Overview
1.1 Product Definition
1.2 Oxycodone Hydrochloride Analgesic Market by Type
1.2.1 Global Oxycodone Hydrochloride Analgesic Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Tablets
1.2.3 Injections
1.3 Oxycodone Hydrochloride Analgesic Market by Application
1.3.1 Global Oxycodone Hydrochloride Analgesic Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Oxycodone Hydrochloride Analgesic Market Dynamics
2.1 Oxycodone Hydrochloride Analgesic Industry Trends
2.2 Oxycodone Hydrochloride Analgesic Industry Drivers
2.3 Oxycodone Hydrochloride Analgesic Industry Opportunities and Challenges
2.4 Oxycodone Hydrochloride Analgesic Industry Restraints
3 Global Growth Perspective
3.1 Global Oxycodone Hydrochloride Analgesic Market Perspective (2020-2031)
3.2 Global Oxycodone Hydrochloride Analgesic Growth Trends by Region
3.2.1 Global Oxycodone Hydrochloride Analgesic Market Size by Region: 2020 VS 2024 VS 2031
3.2.2 Global Oxycodone Hydrochloride Analgesic Market Size by Region (2020-2025)
3.2.3 Global Oxycodone Hydrochloride Analgesic Market Size by Region (2026-2031)
4 Competitive Landscape by Players
4.1 Global Oxycodone Hydrochloride Analgesic Revenue by Players
4.1.1 Global Oxycodone Hydrochloride Analgesic Revenue by Players (2020-2025)
4.1.2 Global Oxycodone Hydrochloride Analgesic Revenue Market Share by Players (2020-2025)
4.1.3 Global Oxycodone Hydrochloride Analgesic Players Revenue Share Top 10 and Top 5 in 2024
4.2 Global Oxycodone Hydrochloride Analgesic Key Players Ranking, 2023 VS 2024 VS 2025
4.3 Global Oxycodone Hydrochloride Analgesic Key Players Headquarters & Area Served
4.4 Global Oxycodone Hydrochloride Analgesic Players, Product Type & Application
4.5 Global Oxycodone Hydrochloride Analgesic Players Establishment Date
4.6 Market Competitive Analysis
4.6.1 Global Oxycodone Hydrochloride Analgesic Market CR5 and HHI
4.6.3 2024 Oxycodone Hydrochloride Analgesic Tier 1, Tier 2, and Tier 3
5 Oxycodone Hydrochloride Analgesic Market Size by Type
5.1 Global Oxycodone Hydrochloride Analgesic Revenue by Type (2020 VS 2024 VS 2031)
5.2 Global Oxycodone Hydrochloride Analgesic Revenue by Type (2020-2031)
5.3 Global Oxycodone Hydrochloride Analgesic Revenue Market Share by Type (2020-2031)
6 Oxycodone Hydrochloride Analgesic Market Size by Application
6.1 Global Oxycodone Hydrochloride Analgesic Revenue by Application (2020 VS 2024 VS 2031)
6.2 Global Oxycodone Hydrochloride Analgesic Revenue by Application (2020-2031)
6.3 Global Oxycodone Hydrochloride Analgesic Revenue Market Share by Application (2020-2031)
7 Company Profiles
7.1 Teva Pharmaceutical Industries Ltd
7.1.1 Teva Pharmaceutical Industries Ltd Comapny Information
7.1.2 Teva Pharmaceutical Industries Ltd Business Overview
7.1.3 Teva Pharmaceutical Industries Ltd Oxycodone Hydrochloride Analgesic Revenue and Gross Margin (2020-2025)
7.1.4 Teva Pharmaceutical Industries Ltd Oxycodone Hydrochloride Analgesic Product Portfolio
7.1.5 Teva Pharmaceutical Industries Ltd Recent Developments
7.2 Mylan
7.2.1 Mylan Comapny Information
7.2.2 Mylan Business Overview
7.2.3 Mylan Oxycodone Hydrochloride Analgesic Revenue and Gross Margin (2020-2025)
7.2.4 Mylan Oxycodone Hydrochloride Analgesic Product Portfolio
7.2.5 Mylan Recent Developments
7.3 Wellso Pharmaceutical
7.3.1 Wellso Pharmaceutical Comapny Information
7.3.2 Wellso Pharmaceutical Business Overview
7.3.3 Wellso Pharmaceutical Oxycodone Hydrochloride Analgesic Revenue and Gross Margin (2020-2025)
7.3.4 Wellso Pharmaceutical Oxycodone Hydrochloride Analgesic Product Portfolio
7.3.5 Wellso Pharmaceutical Recent Developments
7.4 Purdue Pharma
7.4.1 Purdue Pharma Comapny Information
7.4.2 Purdue Pharma Business Overview
7.4.3 Purdue Pharma Oxycodone Hydrochloride Analgesic Revenue and Gross Margin (2020-2025)
7.4.4 Purdue Pharma Oxycodone Hydrochloride Analgesic Product Portfolio
7.4.5 Purdue Pharma Recent Developments
7.5 NEPHARM
7.5.1 NEPHARM Comapny Information
7.5.2 NEPHARM Business Overview
7.5.3 NEPHARM Oxycodone Hydrochloride Analgesic Revenue and Gross Margin (2020-2025)
7.5.4 NEPHARM Oxycodone Hydrochloride Analgesic Product Portfolio
7.5.5 NEPHARM Recent Developments
7.6 Napp Pharmaceuticals
7.6.1 Napp Pharmaceuticals Comapny Information
7.6.2 Napp Pharmaceuticals Business Overview
7.6.3 Napp Pharmaceuticals Oxycodone Hydrochloride Analgesic Revenue and Gross Margin (2020-2025)
7.6.4 Napp Pharmaceuticals Oxycodone Hydrochloride Analgesic Product Portfolio
7.6.5 Napp Pharmaceuticals Recent Developments
7.7 Mallinckrodt
7.7.1 Mallinckrodt Comapny Information
7.7.2 Mallinckrodt Business Overview
7.7.3 Mallinckrodt Oxycodone Hydrochloride Analgesic Revenue and Gross Margin (2020-2025)
7.7.4 Mallinckrodt Oxycodone Hydrochloride Analgesic Product Portfolio
7.7.5 Mallinckrodt Recent Developments
7.8 Epic Pharma, LLC
7.8.1 Epic Pharma, LLC Comapny Information
7.8.2 Epic Pharma, LLC Business Overview
7.8.3 Epic Pharma, LLC Oxycodone Hydrochloride Analgesic Revenue and Gross Margin (2020-2025)
7.8.4 Epic Pharma, LLC Oxycodone Hydrochloride Analgesic Product Portfolio
7.8.5 Epic Pharma, LLC Recent Developments
7.9 Amneal Pharmaceuticals, Inc.(Impax)
7.9.1 Amneal Pharmaceuticals, Inc.(Impax) Comapny Information
7.9.2 Amneal Pharmaceuticals, Inc.(Impax) Business Overview
7.9.3 Amneal Pharmaceuticals, Inc.(Impax) Oxycodone Hydrochloride Analgesic Revenue and Gross Margin (2020-2025)
7.9.4 Amneal Pharmaceuticals, Inc.(Impax) Oxycodone Hydrochloride Analgesic Product Portfolio
7.9.5 Amneal Pharmaceuticals, Inc.(Impax) Recent Developments
8 North America
8.1 North America Oxycodone Hydrochloride Analgesic Revenue (2020-2031)
8.2 North America Oxycodone Hydrochloride Analgesic Revenue by Type (2020-2031)
8.2.1 North America Oxycodone Hydrochloride Analgesic Revenue by Type (2020-2025)
8.2.2 North America Oxycodone Hydrochloride Analgesic Revenue by Type (2026-2031)
8.3 North America Oxycodone Hydrochloride Analgesic Revenue Share by Type (2020-2031)
8.4 North America Oxycodone Hydrochloride Analgesic Revenue by Application (2020-2031)
8.4.1 North America Oxycodone Hydrochloride Analgesic Revenue by Application (2020-2025)
8.4.2 North America Oxycodone Hydrochloride Analgesic Revenue by Application (2026-2031)
8.5 North America Oxycodone Hydrochloride Analgesic Revenue Share by Application (2020-2031)
8.6 North America Oxycodone Hydrochloride Analgesic Revenue by Country
8.6.1 North America Oxycodone Hydrochloride Analgesic Revenue by Country (2020 VS 2024 VS 2031)
8.6.2 North America Oxycodone Hydrochloride Analgesic Revenue by Country (2020-2025)
8.6.3 North America Oxycodone Hydrochloride Analgesic Revenue by Country (2026-2031)
8.6.4 United States
8.6.5 Canada
8.6.6 Mexico
9 Europe
9.1 Europe Oxycodone Hydrochloride Analgesic Revenue (2020-2031)
9.2 Europe Oxycodone Hydrochloride Analgesic Revenue by Type (2020-2031)
9.2.1 Europe Oxycodone Hydrochloride Analgesic Revenue by Type (2020-2025)
9.2.2 Europe Oxycodone Hydrochloride Analgesic Revenue by Type (2026-2031)
9.3 Europe Oxycodone Hydrochloride Analgesic Revenue Share by Type (2020-2031)
9.4 Europe Oxycodone Hydrochloride Analgesic Revenue by Application (2020-2031)
9.4.1 Europe Oxycodone Hydrochloride Analgesic Revenue by Application (2020-2025)
9.4.2 Europe Oxycodone Hydrochloride Analgesic Revenue by Application (2026-2031)
9.5 Europe Oxycodone Hydrochloride Analgesic Revenue Share by Application (2020-2031)
9.6 Europe Oxycodone Hydrochloride Analgesic Revenue by Country
9.6.1 Europe Oxycodone Hydrochloride Analgesic Revenue by Country (2020 VS 2024 VS 2031)
9.6.2 Europe Oxycodone Hydrochloride Analgesic Revenue by Country (2020-2025)
9.6.3 Europe Oxycodone Hydrochloride Analgesic Revenue by Country (2026-2031)
9.6.4 Germany
9.6.5 France
9.6.6 U.K.
9.6.7 Italy
9.6.8 Russia
9.6.9 Spain
9.6.10 Netherlands
9.6.11 Switzerland
9.6.12 Sweden
9.6.13 Poland
10 China
10.1 China Oxycodone Hydrochloride Analgesic Revenue (2020-2031)
10.2 China Oxycodone Hydrochloride Analgesic Revenue by Type (2020-2031)
10.2.1 China Oxycodone Hydrochloride Analgesic Revenue by Type (2020-2025)
10.2.2 China Oxycodone Hydrochloride Analgesic Revenue by Type (2026-2031)
10.3 China Oxycodone Hydrochloride Analgesic Revenue Share by Type (2020-2031)
10.4 China Oxycodone Hydrochloride Analgesic Revenue by Application (2020-2031)
10.4.1 China Oxycodone Hydrochloride Analgesic Revenue by Application (2020-2025)
10.4.2 China Oxycodone Hydrochloride Analgesic Revenue by Application (2026-2031)
10.5 China Oxycodone Hydrochloride Analgesic Revenue Share by Application (2020-2031)
11 Asia (Excluding China)
11.1 Asia Oxycodone Hydrochloride Analgesic Revenue (2020-2031)
11.2 Asia Oxycodone Hydrochloride Analgesic Revenue by Type (2020-2031)
11.2.1 Asia Oxycodone Hydrochloride Analgesic Revenue by Type (2020-2025)
11.2.2 Asia Oxycodone Hydrochloride Analgesic Revenue by Type (2026-2031)
11.3 Asia Oxycodone Hydrochloride Analgesic Revenue Share by Type (2020-2031)
11.4 Asia Oxycodone Hydrochloride Analgesic Revenue by Application (2020-2031)
11.4.1 Asia Oxycodone Hydrochloride Analgesic Revenue by Application (2020-2025)
11.4.2 Asia Oxycodone Hydrochloride Analgesic Revenue by Application (2026-2031)
11.5 Asia Oxycodone Hydrochloride Analgesic Revenue Share by Application (2020-2031)
11.6 Asia Oxycodone Hydrochloride Analgesic Revenue by Country
11.6.1 Asia Oxycodone Hydrochloride Analgesic Revenue by Country (2020 VS 2024 VS 2031)
11.6.2 Asia Oxycodone Hydrochloride Analgesic Revenue by Country (2020-2025)
11.6.3 Asia Oxycodone Hydrochloride Analgesic Revenue by Country (2026-2031)
11.6.4 Japan
11.6.5 South Korea
11.6.6 India
11.6.7 Australia
11.6.8 Taiwan
11.6.9 Southeast Asia
12 South America, Middle East and Africa
12.1 SAMEA Oxycodone Hydrochloride Analgesic Revenue (2020-2031)
12.2 SAMEA Oxycodone Hydrochloride Analgesic Revenue by Type (2020-2031)
12.2.1 SAMEA Oxycodone Hydrochloride Analgesic Revenue by Type (2020-2025)
12.2.2 SAMEA Oxycodone Hydrochloride Analgesic Revenue by Type (2026-2031)
12.3 SAMEA Oxycodone Hydrochloride Analgesic Revenue Share by Type (2020-2031)
12.4 SAMEA Oxycodone Hydrochloride Analgesic Revenue by Application (2020-2031)
12.4.1 SAMEA Oxycodone Hydrochloride Analgesic Revenue by Application (2020-2025)
12.4.2 SAMEA Oxycodone Hydrochloride Analgesic Revenue by Application (2026-2031)
12.5 SAMEA Oxycodone Hydrochloride Analgesic Revenue Share by Application (2020-2031)
12.6 SAMEA Oxycodone Hydrochloride Analgesic Revenue by Country
12.6.1 SAMEA Oxycodone Hydrochloride Analgesic Revenue by Country (2020 VS 2024 VS 2031)
12.6.2 SAMEA Oxycodone Hydrochloride Analgesic Revenue by Country (2020-2025)
12.6.3 SAMEA Oxycodone Hydrochloride Analgesic Revenue by Country (2026-2031)
12.6.4 Brazil
12.6.5 Argentina
12.6.6 Chile
12.6.7 Colombia
12.6.8 Peru
12.6.9 Saudi Arabia
12.6.10 Israel
12.6.11 UAE
12.6.12 Turkey
12.6.13 Iran
12.6.14 Egypt
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.